News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UMH Properties will present at the Philadelphia Securities Association luncheon on Oct 7, 2026.
  • UMH is a public equity REIT focused on manufactured home communities and self-storage.
  • Management will provide an overview of the company's operations and portfolio during the presentation.
  • A Q&A session will follow the presentation.
  • Presentation materials will be made available on UMH's website after the event.
  • The event is aimed at investors and analysts seeking updates on UMH's portfolio and strategy.

Latest Articles

BofA Upgrade Fuels Pre-Market Rally in T-Mobile Shares

BofA Upgrade Fuels Pre-Market Rally in T-Mobile Shares

T-Mobile shares climbed in pre-market trading after BofA Securities upgraded the stock to Buy from Neutral and set a $220 price target. The bank argued that worries about peak competitive pressure have been exaggerated and highlighted T-Mobile's partnership value, limited exposure to low earth orbit broadband threats, and pricing flexibility. The u…

Raymond James Lowers Ratings on Delta and JetBlue Ahead of Q2 Results

Raymond James Lowers Ratings on Delta and JetBlue Ahead of Q2 Results

Raymond James adjusted its ratings on two major U.S. airlines ahead of second-quarter earnings, trimming Delta Air Lines to Outperform from Strong Buy and cutting JetBlue Airways to Underperform from Market Perform. The firm flagged Delta's supportive fundamentals but limited near-term upside after a recent share rally, and highlighted JetBlue's co…

AX Coin, a Subsidiary of SOLOWIN HOLDINGS (Nasdaq: AXG), Partners with Bank of Bahrain and Kuwait B.S.C. to Advance Regulated Stablecoin Infrastructure for Institutional Banking

AX Coin, a Subsidiary of SOLOWIN HOLDINGS (Nasdaq: AXG), Partners with Bank of Bahrain and Kuwait B.S.C. to Advance Regulated Stablecoin Infrastructure for Institutional Banking

SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary, AX Coin Bahrain, has signed a non-binding MOU with the Bank of Bahrain and Kuwait to explore developing regulated stablecoin infrastructure aimed at institutional payments, treasury operations, and cross-border settlements. This partnership seeks to leverage AX Coin's digital asset exper…

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia

TG Therapeutics announced the start of a Phase 2 open-label clinical trial testing BRIUMVI (ublituximab-xiiy) in about 60 adults with treatment-resistant schizophrenia. This trial aims to assess the drug's efficacy and safety by measuring symptom improvement through standard clinical scales. BRIUMVI is already FDA-approved for relapsing multiple sc…

FreightCar America, Inc. Announces Milestone Multi-Year Order for 1,900 Railcars; Second Quarter Orders for Approximately 3,000 Railcars Represent a Commercial Inflection Point

FreightCar America, Inc. Announces Milestone Multi-Year Order for 1,900 Railcars; Second Quarter Orders for Approximately 3,000 Railcars Represent a Commercial Inflection Point

FreightCar America announced a milestone multi-year contract for 1,900 railcars through 2028 with a key customer, along with approximately 3,000 railcar orders in Q2 totaling around $300 million. This surge in orders across core market segments highlights growing demand and expanding backlog visibility, representing a commercial inflection point fo…

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

CervoMed Inc. presents five scientific presentations at the Alzheimer's Association International Conference 2026 detailing the clinical progress of neflamapimod, its leading oral drug candidate for treating dementia with Lewy bodies (DLB). Data suggest neflamapimod may slow disease progression, improve cognitive and functional outcomes, and impact…

Citi Cuts Nintendo Price Target After Software Sales Outlook Weakens

Citi Cuts Nintendo Price Target After Software Sales Outlook Weakens

Citi reduced its price target for Nintendo to ¥9,300 from ¥11,000 while retaining a Buy recommendation, citing downward revisions to software unit sales and higher R&D costs following Nintendo's June 9 presentation. The bank also lowered operating profit forecasts for fiscal years 2027 and 2028 and trimmed the valuation multiple to reflect changes …

Bank of England appoints Rhys Phillips as chief cashier to oversee banknote supply

Bank of England appoints Rhys Phillips as chief cashier to oversee banknote supply

The Bank of England has named Rhys Phillips as its next chief cashier, succeeding Victoria Cleland. Phillips, currently the governor's principal private secretary, will take on executive director duties on October 19 and oversee a planned redesign of sterling banknotes that replaces historical figures with wildlife images. Cleland will leave the Ba…

Societe Generale Shares Lifted by Kepler Upgrade and Positive Credit Outlook

Societe Generale Shares Lifted by Kepler Upgrade and Positive Credit Outlook

Societe Generale shares climbed after Kepler Cheuvreux upgraded the stock to Buy and sharply raised its price target, citing a merger-of-equals scenario with Deutsche Bank. A recent positive revision to the bank's credit outlook by S&P Global and a supportive macro backdrop also contributed to investor optimism, driving the share price toward its 5…

Vera Therapeutics Shares Climb Ahead of July 7 FDA Decision on Atacicept

Vera Therapeutics Shares Climb Ahead of July 7 FDA Decision on Atacicept

Vera Therapeutics (NASDAQ: VERA) saw its stock rise 6% on Monday as market participants positioned ahead of the U.S. Food and Drug Administration's July 7 Prescription Drug User Fee Act decision on atacicept for adults with IgA nephropathy. The regulator will rule on the company's Biologics License Application for accelerated approval, while Vera h…